Á. S. Huerta

发表

Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain

C. G. Ponce, S. P. Suela, E. E. Cardeñosa, 2008, Breast Cancer Research and Treatment.

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

C. G. Ponce, Inmaculada de Juan Jiménez, S. P. Suela, 2010, Breast Cancer Research and Treatment.

Non‐Hodgkin's Lymphoma in Older People: Age Is Not Always an Adverse Prognostic Factor

J. Pérez-Fidalgo, J. Gomez-Codina, R. Díaz, 2002, Journal of the American Geriatrics Society.

Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence

C. G. Ponce, Inmaculada de Juan Jiménez, S. P. Suela, 2013, Familial Cancer.

Patterns of death among patients treated at a Department of Medical Oncology in Spain

J. M. Saera, J. A. Urtasun, R. D. Beveridge, 2004 .

High risk Ewing's sarcomas. Effectiveness and toxicity of a regimen designed for children and used in adults

J. Pérez-Fidalgo, J. M. Salcedo, Á. S. Huerta, 2004 .

Non-Hodgkin’s lymphoma in the elderly. Age is not always an adverse prognostic factor

J. Pérez-Fidalgo, J. Gomez-Codina, Á. S. Huerta, 2002, Revista de Oncología.

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers

I. Chirivella González, C. G. Ponce, Inmaculada de Juan Jiménez, 2009, Breast Cancer Research and Treatment.

Primitive non Hodgkin’s lymphoma of the pancreas in a patient with HIV infection

V. Ibáñez, J. A. Urtasun, R. D. Beveridge, 2003, Revista de Oncología.

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.

F. Aparisi, P. R. Aznar, R. D. Beveridge, 2007 .

Relationship of BRCA1 and BRCA2 mutations with cancer burden in the family and tumor incidence

I. Chirivella González, C. G. Ponce, Inmaculada de Juan Jiménez, 2010, Familial Cancer.

Toxic Epidermal Necrolysis Associated with Interleukin-2

G. Reynés, A. Yuste, Á. S. Huerta, 2002, The Annals of pharmacotherapy.

The addition of oxaliplatin to the mayo clinic schedule significantly increases its toxicity: a retrospective analysis of patients with advanced colorectal cancer

J. A. Urtasun, Á. S. Huerta, R. G. Sarrió, 2003, Revista de Oncología.

Low penetrance alleles as risk modifiers in familial and sporadic breast cancer

Inmaculada de Juan Jiménez, S. P. Suela, E. E. Cardeñosa, 2012, Familial Cancer.

Persistent fever due to sepsis caused byMycobacterium abscessus in a patient with cancer

R. D. Beveridge, Á. S. Huerta, R. G. Sarrió, 2004 .

Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience

J. A. Urtasun, R. D. Beveridge, A. G. Ortiz, 2014, Medical Oncology.

SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

R. García-Carbonero, E. G. Pulido, J. G. Plazas, 2023, Clinical and Translational Oncology.

Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family

C. G. Ponce, Inmaculada de Juan Jiménez, S. P. Suela, 2008, Breast Cancer Research and Treatment.